Paxlovid Shows No Benefit for Long COVID in NIH-Funded Trial
A NIH-funded trial found Paxlovid did not improve Long COVID symptoms versus placebo in 959 adults.
Results and updates from clinical trials testing new drugs, therapies and approaches to care.
Oxford trial explores vaccine approach against Ebola strain as UK research accelerates
Oxford launches an Ebola vaccine trial targeting the Bundibugyo strain, highlighting new progress in UK infectious disease research.
UK Researchers Push Ahead With Psilocybin Therapy Trials in the NHS
UK trial shows encouraging psilocybin therapy safety, while raising key questions about NHS delivery and implementation.
Early Pathology Review Urged to Sharpen Biologically Rich Cancer Trials
A Nature perspective says early pathology input can strengthen biologically rich cancer trials and improve research design.
Early Pathology Input Strengthens the Future of Cancer Trials, Study Says
A new study says pathology should be embedded early in cancer trial design to improve feasibility and trial quality.
NHS Trial Reports Safer Intravenous Iron Use Before Cardiac Surgery
New BMJ research explores intravenous iron before cardiac surgery and what it could mean for pre-operative anaemia care.
Paxlovid Fails to Ease Long COVID Symptoms in NIH-Funded Trial
Paxlovid did not improve Long COVID symptoms in a large NIH-funded trial published in Lancet Infectious Diseases.
First UK Patient Receives Bespoke Lung Cancer Vaccine in Early Trial
A UK patient receives a bespoke lung cancer vaccine in an MRC-funded trial exploring personalised cancer treatment.
First UK Patient Receives Bespoke Lung Cancer Vaccine in Early Trial
Bespoke lung cancer vaccine given to first UK patient in early MRC-funded trial at Clatterbridge Cancer Centre.
Oxford Starts UK Trial of Ebola Vaccine Against Bundibugyo Strain
Oxford has started a UK Ebola vaccine trial targeting the Bundibugyo strain, marking a fresh step in infectious disease research.
